Journal of Literature Pharmacy Sciences

Farmasötik Bakış Açısıyla Biyoaktif Camlar: Sistematik Derleme
Bioactive Glasses from a Pharmaceutical Perspective: Systematic Reviews
Müge KILIÇARSLANa, Cemre Nur GENCELa
aAnkara Üniversitesi Eczacılık Fakültesi, Farmasötik Teknoloji ABD, Ankara, TÜRKİYE
J Lit Pharm Sci. 2021;10(2):241-56
doi: 10.5336/pharmsci.2021-82521
Article Language: TR
Full Text
ÖZET
 Biyomateryaller arasında yer alan biyoseramiklerin yüzey reaktif grubunu oluşturan biyoaktif camlar, biyoaktivite özellikleri ve dokularla bağ oluşturabilme yetenekleri sayesinde başta kemik doku mühendisliği olmak üzere çeşitli uygulamalarda, özellikle doku rejenerasyonu amacıyla ilgi gören bir sistemdir ve piyasada farklı kullanım alanlarına sahip preparatları bulunmaktadır. Farmasötik alanda biyoaktif camlar; etken maddeleri, iyonları, peptid ve proteinleri, hormon ve büyüme faktörleri gibi biyoaktif molekülleri iletmek için taşıyıcı olarak kullanıldıklarında sinerjik etki sağlanabildiği tespit edilmiştir. Biyoaktif camlar, kendine özgü özellikleri sayesinde daha yüksek verimlilik ve daha düşük toksisite sergileyen ilaç taşıyıcı sistemlerin geliştirilebilmesine imkân tanır. Çeşitli modifikasyonlara uygun olan yapısı, kontrollü salım ve ilaç hedefleme amacıyla kullanımlarını mümkün kılar. Bu amaçla genellikle nano/mikro partiküler yapıda polimerlerle kompozit hâlinde veya mezoporöz ve fiber yapılara sahip biyoaktif camların kullanımı tercih edilir. Etken maddeler, biyoaktif camlara sol-jel prosesi ile camın sentezi sırasında veya immersiyon yoluyla dâhil edilebilir. Bu derlemede, biyoaktif camlara genel bir bakış açısı sunulması, uygulama ve kullanım alanları hakkında bilgi verilmesi ve bugüne kadar yapılan çalışmalarla destekleyerek, farmasötik alandaki uygulamaları ve ilaç taşıyıcı sistem olarak biyoaktif camların kullanımının değerlendirilmesi amaçlanmıştır.

Anahtar Kelimeler: Biyoaktif cam; biyoaktivite; biyouyumluluk; rejeneratif tıp; doku mühendisliği; katı-jel faz geçişleri; ilaç taşıyıcı sistemler; kontrollü ilaç salım sistemleri; ilaç hedefleme
ABSTRACT
 Bioactive glasses that composes of surface reactive group of which is bioceramics among biomaterials, by the means of their attributes and abilities of tissue bonding they attract a great deal of interest among several applications particularly bone tissue engineering specifically for the purpose of tissue regeneration and they have preparations that have different fields of usage. In the pharmaceutical field it has been observed that when bioactive glasses are used as carriers to transmit bioactive molecules such as active ingredients, ions, peptides and proteins synergic effect can be yielded. Bioactive glasses with their own unique characteristics make possible to develop drug delivery systems which display more efficiency and less toxicity. With their structure which is applicable to various modifications they make possible their fields of usage for the purposes of controlled release and drug targeting. For this reason, it is preferred to usually use bioactive glasses as in forms of mesoporous and fiber structure or composited with polymers in nano/micro particle level. Active ingredients can be incorporated into bioactive glasses at solgel process during the synthesis of the glass or with the immersion. In this review, it is intended to offer an overall perspective about bioactive glasses, to inform about their fields of application and usage and to assess their usage in pharmaceutical field and as drug delivery systems with proving studies done so far.

Keywords: Bioactive glass; bioactivity; biocompatibility; regenerative medicine; tissue engineering; sol-gel phase transition; drug delivery systems; controlled drug delivery systems; drug targeting
REFERENCES:
  1. Kaur G, Pandey OP, Singh K, Homa D, Scott B, Pickrell G. A review of bioactive glasses: Their structure, properties, fabrication and apatite formation. J Biomed Mater Res A. 2014;102(1):254-74. [Crossref] [PubMed] 
  2. Ceyhan T, Günay V, Capoğlu A, Sayrak H, Karaca C. Bir cam-seramik biyomalzemenin üretimi, tanimlanmasi ve biyolojik etkilerinin canli-dişi ve canli-içi ortamda değerlendirilmesi [Production and characterization of a glass-ceramic biomaterial and in vitro and in vivo evaluation of its biological effects]. Acta Orthop Traumatol Turc. 2007;41(4):307-13. [PubMed] 
  3. Brunner TJ, Stark WJ, Boccaccini AR. Nanoscale bioactive silicate glasses in biomedical applications. In: Kumar C, ed. Nanostructured Oxides (Nanomaterials for Life Sciences). 1st ed. Weinheim: Wiley-VCH; 2009. p.203-20. [Link] 
  4. Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater. 2013;9(1):4457-86. [Crossref] [PubMed] 
  5. Kargozar S, Baino F, Hamzehlou S, Hill RG, Mozafari M. Bioactive glasses entering the mainstream. Drug Discov Today. 2018;23(10):1700-4. [Crossref] [PubMed] 
  6. Hench LL. The story of Bioglass. J Mater Sci Mater Med. 2006;17(11):967-78. [Crossref] [PubMed] 
  7. Borges R, Kai KC, Marchi J. Biocompatible glasses for controlled release technology. In: Marchi J, ed. Biocompatible Glasses: From Bone Regeneration to Cancer Treatment. Advanced Structured Materials, 53. 1st ed. Cham: Springer International Publishing; 2016. p.285-315. [Crossref] 
  8. Hoppe A, Güldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials. 2011;32(11):2757-74. [Crossref] [PubMed] 
  9. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res. 2001;55(2):151-7. [Crossref] [PubMed] 
  10. Gorustovich AA, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev. 2010;16(2):199-207. [Crossref] [PubMed] 
  11. Hu S, Chang J, Liu M, Ning C. Study on antibacterial effect of 45S5 Bioglass. J Mater Sci Mater Med. 2009;20(1):281-6. [Crossref] [PubMed] 
  12. Day RM, Boccaccini AR. Effect of particulate bioactive glasses on human macrophages and monocytes in vitro. J Biomed Mater Res A. 2005;73(1):73-9. [Crossref] [PubMed] 
  13. Baino F, Hamzehlou S, Kargozar S. Bioactive Glasses: Where are we and where are we going? J Funct Biomater. 2018;9(1):25. [Crossref] [PubMed] [PMC] 
  14. Jones JR, Brauer DS, Hupa L, Greenspan DC. Bioglass and bioactive glasses and their impact on healthcare. Int J Appl Glass Sci. 2016;7(4):423-34. [Crossref] 
  15. Alsharabasy AM. A mini-review on the bioactive glass-based composites in soft tissue repair. Bioceram Dev Appl. 2018;8(1):1-4. [Link] 
  16. Hench LL, Jones JR. Bioactive glasses: frontiers and challenges. Front Bioeng Biotechnol. 2015;3:194. [Crossref] [PubMed] [PMC] 
  17. Merwin GE. Bioglass middle ear prosthesis: preliminary report. Ann Otol Rhinol Laryngol. 1986;95(1 Pt 1):78-82. [Crossref] [PubMed] 
  18. Zamet JS, Darbar UR, Griffiths GS, Bulman JS, Brägger U, Bürgin W, et al. Particulate bioglass as a grafting material in the treatment of periodontal intrabony defects. J Clin Periodontol. 1997;24(6):410-8. [Crossref] [PubMed] 
  19. Fiume E, Barberi J, Verné E, Baino F. Bioactive Glasses: from parent 45S5 composition to scaffold-assisted tissue-healing therapies. J Funct Biomater. 2018;9(1):24. [Crossref] [PubMed] [PMC] 
  20. Banerjee A, Hajatdoost-Sani M, Farrell S, Thompson I. A clinical evaluation and comparison of bioactive glass and sodium bicarbonate air-polishing powders. J Dent. 2010;38(6):475-9. [Crossref] [PubMed] 
  21. Ma X, Schou KR, Maloney-Schou M, Harwin FM, Ng JD. The porous polyethylene/bioglass spherical orbital implant: a retrospective study of 170 cases. Ophthalmic Plast Reconstr Surg. 2011;27(1):21-7. [Crossref] [PubMed] 
  22. Lin Y, Mauro JC, Kaur G. Bioactive glasses for cancer therapy. In: Kaur G, ed. Biomedical, Therapeutic and Clinical Applications of Bioactive Glasses. Woodhead Publishing Series in Biomaterials. 1st ed. Cambridge: Woodhead Publishing; 2019. p.273-312. [Link] 
  23. Miguez-Pacheco V, Hench LL, Boccaccini AR. Bioactive glasses beyond bone and teeth: emerging applications in contact with soft tissues. Acta Biomater. 2015;13:1-15. [Crossref] [PubMed] 
  24. Gantar A, da Silva LP, Oliveira JM, Marques AP, Correlo VM, Novak S, et al. Nanoparticulate bioactive-glass-reinforced gellan-gum hydrogels for bone-tissue engineering. Mater Sci Eng C Mater Biol Appl. 2014;43:27-36. [Crossref] [PubMed] 
  25. Rottensteiner U, Sarker B, Heusinger D, Dafinova D, Rath SN, Beier JP, et al. In vitro and in vivo biocompatibility of alginate dialdehyde/gelatin hydrogels with and without nanoscaled bioactive glass for bone tissue engineering applications. Materials (Basel). 2014;7(3):1957-74. [Crossref] [PubMed] [PMC] 
  26. Oliveira MB, Luz GM, Mano JF. A combinatorial study of nanocomposite hydrogels: on-chip mechanical/viscoelastic and pre-osteoblast interaction characterization. J Mater Chem B. 2014;2(34):5627-38. [Crossref] [PubMed] 
  27. Wilda H, Gough JE. In vitro studies of annulus fibrosus disc cell attachment, differentiation and matrix production on PDLLA/45S5 Bioglass composite films. Biomaterials. 2006;27(30):5220-9. [Crossref] [PubMed] 
  28. Rego SJ, Vale AC, Luz GM, Mano JF, Alves NM. Adhesive bioactive coatings inspired by Sea Life. Langmuir. 2016;32(2):560-8. [Crossref] [PubMed] 
  29. Waltimo T, Mohn D, Paqué F, Brunner TJ, Stark WJ, Imfeld T, et al. Fine-tuning of bioactive glass for root canal disinfection. J Dent Res. 2009;88(3):235-8. [Crossref] [PubMed] 
  30. Mohn D, Zehnder M, Imfeld T, Stark WJ. Radio-opaque nanosized bioactive glass for potential root canal application: evaluation of radiopacity, bioactivity and alkaline capacity. Int Endod J. 2010;43(3):210-7. [Crossref] [PubMed] 
  31. Vollenweider M, Brunner TJ, Knecht S, Grass RN, Zehnder M, Imfeld T, et al. Remineralization of human dentin using ultrafine bioactive glass particles. Acta Biomater. 2007;3(6):936-43. [Crossref] [PubMed] 
  32. Srinivasan S, Jayasree R, Chennazhi KP, Nair SV, Jayakumar R. Biocompatible alginate/nano bioactive glass ceramic composite scaffolds for periodontal tissue regeneration. Carbohydr Polym. 2012;87(1):274-83. [Crossref] 
  33. Day RM, Boccaccini AR, Shurey S, Roether JA, Forbes A, Hench LL, et al. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials. 2004;25(27):5857-66. [Crossref] [PubMed] 
  34. Joo NY, Knowles JC, Lee GS, Kim JW, Kim HW, Son YJ, et al. Effects of phosphate glass fiber-collagen scaffolds on functional recovery of completely transected rat spinal cords. Acta Biomater. 2012;8(5):1802-12. [Crossref] [PubMed] 
  35. Verrier S, Blaker JJ, Maquet V, Hench LL, Boccaccini AR. PDLLA/Bioglass composites for soft-tissue and hard-tissue engineering: an in vitro cell biology assessment. Biomaterials. 2004;25(15):3013-21. [Crossref] [PubMed] 
  36. Barabadi Z, Azami M, Sharifi E, Karimi R, Lotfibakhshaiesh N, Roozafzoon R, et al. Fabrication of hydrogel based nanocomposite scaffold containing bioactive glass nanoparticles for myocardial tissue engineering. Mater Sci Eng C Mater Biol Appl. 2016;69:1137-46. [Crossref] [PubMed] 
  37. Santos L, Ferraz MP, Shirosaki Y, Lopes MA, Fernandes MH, Osaka A, et al. Degradation studies and biological behavior on an artificial cornea material. Invest Ophthalmol Vis Sci. 2011;52(7):4274-81. [Crossref] [PubMed] 
  38. Rai R, Boccaccini AR, Knowles JC, Locke IC, Gordge MP, McCormick A, et al. Fabrication of a novel poly (3-hydroxyoctanoate)/nanoscale bioactive glass composite film with potential as a multifunctional wound dressing. In: D'Amore A, Acierno D, Grassia L, eds. V International Conference on Times of Polymers (TOP) and Composites. AIP Conference Proceedings/Materials Physics and Applications, No 1255. 2010th ed. New York: American Institute of Physics; 2010. p.126-8. [Link] 
  39. Hong KS, Kim EC, Bang SH, Chung CH, Lee YI, Hyun JK, et al. Bone regeneration by bioactive hybrid membrane containing FGF2 within rat calvarium. J Biomed Mater Res A. 2010;94(4):1187-94. [Crossref] [PubMed] 
  40. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chemistry. 2006;12(23):5934-43. [Crossref] [PubMed] 
  41. Hum J, Boccaccini AR. Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review. J Mater Sci Mater Med. 2012;23(10):2317-33. [Crossref] [PubMed] 
  42. Erol-Taygun M, Zheng K, Boccaccini AR. Nanoscale bioactive glasses in medical applications. Int J Appl Glass Sci. 2013;4(2):136-48. [Crossref] 
  43. Skallevold HE, Rokaya D, Khurshid Z, Zafar MS. Bioactive glass applications in dentistry. Int J Mol Sci. 2019;20(23):5960. [Crossref] [PubMed] [PMC] 
  44. Boccaccini AR, Erol M, Stark WJ, Mohn D, Hong Z, Mano JF. Polymer/bioactive glass nanocomposites for biomedical applications: a review. Compos Sci Technol. 2010;70(13):1764-76. [Crossref] 
  45. Zambanini T, Borges R, Marchi J. Bioactive glass/polymer composites for drug delivery. In: Kaur G, eds. Clinical Applications of Biomaterials: State-of-the-Art Progress, Trends, and Novel Approaches. 1st ed. Cham: Springer International Publishing; 2017. p.287-311. [Link] 
  46. Zheng K, Boccaccini AR. Sol-gel processing of bioactive glass nanoparticles: A review. Adv Colloid Interface Sci. 2017;249:363-73. [Crossref] [PubMed] 
  47. Arcos D, Vallet-Regí M. Bioceramics for drug delivery. Acta Mater. 2013;61(3):890-911. [Crossref] 
  48. Izquierdo-Barba I, Vallet-Regí M. Mesoporous bioactive glasses: Relevance of their porous structure compared to that of classical bioglasses. Biomed Glasses. 2015;1:140-50. [Crossref] 
  49. Kaur G, Kumar V, Baino F, Mauro JC, Pickrell G, Evans I, et al. Mechanical properties of bioactive glasses, ceramics, glass-ceramics and composites: State-of-the-art review and future challenges. Mater Sci Eng C Mater Biol Appl. 2019;104:109895. [Crossref] [PubMed] 
  50. Ding Y, Souza MT, Li W, Schubert DW, Boccaccini AR, Roether JA. Bioactive glass-biopolymer composites. In: Antoniac IV, ed. Handbook of Bioceramics and Biocomposites. 1st ed. Cham: Springer International Publishing; 2015. p.1-26. [Crossref] 
  51. Poologasundarampillai G, Obata A. Electrospun bioactive glass and organic-inorganic hybrid fibers for tissue regeneration and drug delivery. In: Dong Y, Baji A, Ramakrishna S, eds. Electrospun Polymers and Composites: Ultrafine Materials, High Performance Fibers and Wearables. Woodhead Publishing Series in Composites Science and Engineering. 1st ed. Cambridge: Woodhead Publishing; 2021. p.77-110. [Link] 
  52. Penide J, Quintero F, del Val J, Comesa-a R, Lusqui-os F, Riveiro A, et al. Bioactive glass nanofibers for tissue engineering. In: Grumezescu V, Grumezescu AM, eds. Materials for Biomedical Engineering: Inorganic Micro- and Nanostructures. 1st ed. Amsterdam: Elsevier; 2019. p. 329-56. [Link] 
  53. Domingues ZR, Cortés ME, Gomes TA, Diniz HF, Freitas CS, Gomes JB, et al. Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with beta-cyclodextrin. Biomaterials. 2004;25(2):327-33. [Crossref] [PubMed] 
  54. Dziadek M, Dziadek K, Checinska K, Zagrajczuk B, Golda-Cepa M, Brzychczy-Wloch M, et al. PCL and PCL/bioactive glass biomaterials as carriers for biologically active polyphenolic compounds: Comprehensive physicochemical and biological evaluation. Bioact Mater. 2021;6(6):1811-26. [Crossref] 
  55. Abdel-Salam FS, Elkheshen SA, Mahmoud AA, Basalious EB, Amer MS, Mostafa AA, et al. In-situ forming chitosan implant-loaded with raloxifene hydrochloride and bioactive glass nanoparticles for treatment of bone injuries: Formulation and biological evaluation in animal model. Int J Pharm. 2020;580:119213. [Crossref] [PubMed] 
  56. El-Kady AM, Farag MM. Bioactive glass nanoparticles as a new delivery system for sustained 5-fluorouracil release: characterization and evaluation of drug release mechanism. J Nanomater. 2015:1-11. [Crossref] 
  57. El-Sayed SAM, Mabrouk M, Khallaf ME, Abd El-Hady BM, El-Meliegy E, Shehata MR. Antibacterial, drug delivery, and osteoinduction abilities of bioglass/chitosan scaffolds for dental applications. J Drug Deliv Sci Technol. 2020;57:101757. [Crossref] 
  58. Rivadeneira J, Luz GM, Audisio MC, Mano JF, Gorustovich AA. Novel antibacterial bioactive glass nanocomposite functionalized with tetracycline hydrochloride. Biomed Glasses. 2015;1:128-35. [Crossref] 
  59. Yang C, Wu H, Li G. Bioactive ophiopogonin release form bioglass-collagen-phosphatidylserine scaffolds to enhance bone repair in vitro. Mater Lett. 2020;265:127436. [Crossref] 
  60. Mouri-o V, Newby P, Pishbin F, Cattalini JP, Lucangioli S, Boccaccini AR. Physicochemical, biological and drug-release properties of gallium crosslinked alginate/nanoparticulate bioactive glass composite films. Soft Matter. 2011;7(14):6705-12. [Crossref] 
  61. Wu C, Zhang Y, Ke X, Xie Y, Zhu H, Crawford R, et al. Bioactive mesopore-glass microspheres with controllable protein-delivery properties by biomimetic surface modification. J Biomed Mater Res A. 2010;95(2):476-85. [Crossref] [PubMed] 
  62. Wu J, Miao G, Zheng Z, Li Z, Ren W, Wu C, et al. 3D printing mesoporous bioactive glass/sodium alginate/gelatin sustained release scaffolds for bone repair. J Biomater Appl. 2019;33(6):755-65. [Crossref] [PubMed] 
  63. Fu S, Du X, Zhu M, Tian Z, Wei D, Zhu Y. 3D printing of layered mesoporous bioactive glass/sodium alginate-sodium alginate scaffolds with controllable dual-drug release behaviors. Biomed Mater. 2019;14(6):065011. [Crossref] [PubMed] 
  64. Lin HM, Lin HY, Chan MH. Preparation, characterization, and in vitro evaluation of folate-modified mesoporous bioactive glass for targeted anticancer drug carriers. J Mater Chem B. 2013;1(44):6147-56. [Crossref] [PubMed] 
  65. Hu M, Fang J, Zhang Y, Wang X, Zhong W, Zhou Z. Design and evaluation a kind of functional biomaterial for bone tissue engineering: Selenium/mesoporous bioactive glass nanospheres. J Colloid Interface Sci. 2020;579:654-66. [Crossref] [PubMed] 
  66. Nawaz Q, Fuentes-Chandía M, Tharmalingam V, Rehman MAU, Leal-Ega-a A, Boccaccini AR. Silibinin releasing mesoporous bioactive glass nanoparticles with potential for breast cancer therapy. Ceram Int. 2020;46(18):29111-9. [Crossref] 
  67. Shoaib M, Ur Rahman MS, Saeed A, Naseer MM. Mesoporous bioactive glass-polyurethane nanocomposites as reservoirs for sustained drug delivery. Colloids Surf B Biointerfaces. 2018;172:806-11. [Crossref] [PubMed] 
  68. El-Fiqi A, Kim JH, Kim HW. Osteoinductive fibrous scaffolds of biopolymer/mesoporous bioactive glass nanocarriers with excellent bioactivity and long-term delivery of osteogenic drug. ACS Appl Mater Interfaces. 2015;7(2):1140-52. [Crossref] [PubMed] 
  69. Huang CL, Fang W, Huang BR, Wang YH, Dong GC, Lee TM. Bioactive glass as a nanoporous drug delivery system for teicoplanin. Appl Sci (Basel). 2020;10(7):2595. [Crossref] 
  70. Xia W, Chang J, Lin J, Zhu J. The pH-controlled dual-drug release from mesoporous bioactive glass/polypeptide graft copolymer nanomicelle composites. Eur J Pharm Biopharm. 2008;69(2):546-52. [Crossref] [PubMed] 
  71. Xu H, Ge YW, Lu JW, Ke QF, Liu ZQ, Zhu ZA, et al. Icariin loaded-hollow bioglass/chitosan therapeutic scaffolds promote osteogenic differentiation and bone regeneration. Chem Eng J. 2018;354:285-94. [Crossref] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com